Intelligence · Sponsor directory
Pharma & Biotech Companies
Premium sponsor intelligence profiles with pipeline dashboards, drug portfolios, patent hubs, and competitive peer analysis — built for BD, licensing, and research teams.
Quick answer
NovaPharmaNews profiles 1,769 pharmaceutical and biotech companies with SEC identifiers, headquarters, therapeutic focus, and cross-links to pipeline programs, drug portfolios, and US patents. Search by legal name, brand name, or ticker for BD, licensing, and competitive intelligence.
-
Keytruda
-
Kiadis Pharma Netherlands
Kiadis Pharma Netherlands B.V.
-
Kisunla
-
Kite Pharma EU
Kite Pharma EU B.V.
-
Koanaa Healthcare
Koanaa Healthcare GmbH
-
Kostaive
-
Kyprolis
-
L. Molteni &
L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A.
-
LABORATORIOS LORIEN
-
LEO Laboratories
-
La Jolla
La Jolla Limited
-
Laboratoire Aguettant
-
Laboratoire Francais du
Laboratoire Francais du Fractionnement et des Biotechnologies
-
Laboratoires 3M Santé
-
Laboratoires CTRS -
Laboratoires CTRS - Boulogne Billancourt
-
Laboratoires Delbert
-
Laboratoires Juvisé Pharmaceuticals
-
Laboratoires SMB
Laboratoires SMB S.A.
-
Laboratoires Théa
-
Laboratorios Farmacéuticos Rovi
-
Laboratorios Lesvi S.L
Laboratorios Lesvi S.L.
-
Lagevrio
-
Lantheus EU
Lantheus EU Limited
-
Lantheus Germany
Lantheus Germany GmbH
Frequently asked questions
What is the NovaPharmaNews companies directory?
It is a searchable index of 1,769 pharma and biotech organizations — public and private — with ticker symbols, HQ location, company type, and counts of linked pipeline programs, drugs, and patents.
Where does company data come from?
Profiles combine SEC EDGAR filings, ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page for attribution and refresh cadence. Directory content is for professional reference, not investment advice.
How do I find a company by ticker or name?
Use the search box — it matches legal name, common name, and stock ticker. Each company profile links to its pipeline programs, marketed drugs, and related patents where available.